Overview
Urolithiasis refers to the formation of stones (calculi) anywhere in the urinary tract. When stones develop specifically in the bladder, they are called bladder stones or vesical calculi. These hard, mineral‑rich deposits can range from a few millimeters to several centimeters and may cause pain, urinary obstruction, or infection.
- Population affected: While bladder stones can occur at any age, they are most common in men over 50 and in individuals with chronic bladder outlet obstruction (e.g., enlarged prostate). Children can develop bladder stones in regions where diets are low in protein and calcium and where infections are prevalent.
- Prevalence: In the United States, bladder stones account for <0.5% of all urinary stones, compared with kidney stones which represent ~85% of cases.1 Worldwide, the incidence is higher in developing nations, with rates reported up to 5 per 10,000 people in some parts of Asia and the Middle East.2
Symptoms
Bladder stones may be asymptomatic when small, but larger stones often produce a recognizable pattern of signs. Common symptoms include:
- Pain or discomfort: A dull ache in the suprapubic region that can become sharp during urination.
- Frequent urination (polyuria): The urge to void more often than normal, sometimes in small amounts.
- Urgency and dysuria: Sudden need to pass urine and burning or painful urination.
- Hematuria: Visible blood in the urine (pink, red, or brown urine).
- Cloudy or foul‑smelling urine: Often a sign of accompanying infection.
- Intermittent dribbling or incomplete emptying: A feeling that the bladder is not fully emptied.
- Sudden, strong urinary stream followed by a pause (intermittent flow): Caused by a stone temporarily blocking the urethra.
- Lower abdominal swelling: Rare, but may occur if a stone enlarges enough to cause urinary retention.
- Fever, chills, or flank pain: Suggests a concurrent urinary tract infection (UTI) or pyelonephritis and warrants prompt medical attention.
Causes and Risk Factors
Bladder stones form when substances in the urine become supersaturated and crystallize. The process is usually secondary to another condition that promotes crystal aggregation or reduces bladder emptying.
Primary causes
- Urinary stasis: Incomplete bladder emptying (e.g., due to benign prostatic hyperplasia, urethral stricture, neurogenic bladder) allows minerals to settle.
- Chronic urinary tract infections: Certain bacteria, especially Proteus mirabilis, produce urease, which raises urinary pH and encourages struvite stone formation.
- Foreign bodies: Long‑term catheters or surgical sutures can serve as a nidus for stone growth.
- Metabolic abnormalities: Hypercalciuria, hyperuricosuria, cystinuria, and hyperoxaluria increase stone risk.
- Dietary factors: Low fluid intake, high animal‑protein or salt diets, and excessive vitamin D supplementation raise stone‑forming potential.
Risk factors
- Male sex (especially >50 years) – prostate enlargement is common.
- History of urinary tract infections or chronic obstruction.
- Neurogenic bladder (spinal cord injury, multiple sclerosis, diabetes‑related neuropathy).
- Long‑term catheter use.
- Dehydration or inadequate fluid intake.
- Obesity and metabolic syndrome.
- Family history of urolithiasis.
- Certain medications: diuretics, calcium‑based antacids, and some antivirals.
Diagnosis
Diagnosing bladder stones involves a combination of clinical evaluation, laboratory testing, and imaging.
History and physical exam
- Review of urinary symptoms, pain patterns, infection history, and medication use.
- Physical exam focusing on suprapubic tenderness, bladder distention, and prostate assessment in men.
Laboratory tests
- Urinalysis: Detects hematuria, pyuria, crystals, and the presence of bacteria.
- Urine culture: Guides antibiotic therapy if infection is present.
- Serum chemistry: Calcium, phosphate, uric acid, creatinine, and electrolytes to uncover metabolic contributors.
Imaging studies
- Ultrasound (US): First‑line, non‑invasive tool; visualizes echogenic stones with posterior acoustic shadowing.
- Non‑contrast computed tomography (CT): Gold standard for stone detection; provides precise size, location, and density.
- Plain X‑ray (KUB – kidneys, ureters, bladder): Detects radiopaque stones (e.g., calcium oxalate) but misses radiolucent stones such as uric acid.
- Cystoscopy: Direct visual inspection of the bladder; allows simultaneous stone removal in many cases.
Treatment Options
Management is individualized based on stone size, composition, patient comorbidities, and presence of infection.
Conservative measures
- Increased fluid intake: Aim for >2–2.5 L/day of water (unless contraindicated) to dilute urine.
- Dietary modification: Reduce animal protein, sodium, and oxalate‑rich foods; maintain adequate calcium intake.
- Medical expulsive therapy: Alpha‑blockers (e.g., tamsulosin) may help small stones (<5 mm) pass spontaneously, though evidence is stronger for ureteral stones.
Medication
- Antibiotics: Treat any documented UTI before or during stone removal.
- Urine alkalinization: Potassium citrate for uric‑acid stones to raise pH and increase solubility.
- Metabolic therapy: Thiazide diuretics for hypercalciuria, allopurinol for hyperuricemia, or thiolaurea for cystinuria.
Surgical / procedural interventions
- Cystolitholapaxy (laser or ultrasonic): Endoscopic fragmentation of the stone through a resectoscope; most common for stones 0.5–3 cm.
- Cystolithotripsy (percutaneous): Small skin incision allows a nephroscope to reach and crush larger stones.
- Open cystotomy: Reserved for extremely large stones (>3 cm) or when endoscopic methods fail.
- Transurethral removal with stone basket: Effective for smooth, mobile calculi that are small enough to be extracted whole.
Post‑procedure care
- Short course of antibiotics (usually 3–7 days) if infection was present.
- Bladder irrigation may be performed to clear debris.
- Follow‑up imaging (ultrasound or CT) 4–6 weeks after treatment to ensure complete clearance.
Living with Urolithiasis (Bladder Stones)
Even after successful removal, patients often need to adopt habits that minimize recurrence and preserve bladder health.
- Hydration: Keep urine light yellow; carry a water bottle and sip regularly.
- Timed voiding: Empty the bladder every 3–4 hours, especially if you have a condition that reduces bladder contractility.
- Poor urinary flow management: Men with prostate enlargement may benefit from alpha‑blockers or 5‑α‑reductase inhibitors (discuss with urologist).
- Catheter care: If long‑term catheterization is unavoidable, follow strict aseptic technique and change catheters as recommended.
- Regular follow‑up: Annual urine analysis and imaging for high‑risk individuals.
- Weight control and exercise: Reduces metabolic risk factors that contribute to stone formation.
- Medication review: Ask your clinician whether any current drugs could predispose you to stones.
Prevention
Prevention strategies target the underlying mechanisms that cause crystallization.
- Stay well‑hydrated: Aim for a urine output of at least 2 L per day; consider adding citrus juice (lemon, orange) which contains citrate, a natural stone inhibitor.
- Balanced diet:
- Limit sodium to <2,300 mg/day (or <1,500 mg if you have hypertension).
- Moderate animal protein (≈0.8 g/kg body weight).
- Include adequate calcium (1,000–1,200 mg/day) from dairy or fortified sources.
- Reduce oxalate‑rich foods (spinach, rhubarb, nuts) if you have calcium‑oxalate stones.
- Control infection: Promptly treat UTIs, especially those caused by urease‑producing bacteria.
- Manage underlying bladder outlet obstruction: Discuss surgical (e.g., transurethral resection of the prostate) or medical options with a urologist.
- Metabolic evaluation: If you have a personal or family history of stones, have a 24‑hour urine collection to identify abnormalities and receive targeted therapy.
- Avoid chronic catheter use when possible: Intermittent catheterization or suprapubic tubes have lower stone risk than indwelling urethral catheters.
Complications
If bladder stones are left untreated, several serious problems can develop:
- Recurrent urinary tract infections: Stones act as a nidus for bacteria.
- Bladder outlet obstruction: Large stones can block urine flow, leading to acute urinary retention.
- Hemorrhagic cystitis: Persistent irritation may cause significant bleeding.
- Bladder wall damage and diverticula: Chronic pressure can thin the bladder wall, predisposing to rupture.
- Upper‑tract involvement: Persistent obstruction may cause back‑pressure, hydronephrosis, and renal impairment.
- Sepsis: An infected stone can precipitate a life‑threatening systemic infection.
- Reduced quality of life: Chronic pain, frequency, and anxiety about future episodes.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Sudden, severe lower‑abdominal or pelvic pain that does not improve.
- Sudden inability to urinate (complete urinary retention).
- Fever ≥ 38.3 °C (101 °F) with chills, especially together with urinary symptoms.
- Visible blood clots in the urine or gross hematuria accompanied by dizziness or fainting (possible significant blood loss).
- Rapidly worsening shortness of breath or confusion (signs of sepsis).
These symptoms may indicate an obstructing stone, severe infection, or bladder rupture—all require immediate medical attention.
References
- Mayo Clinic. “Bladder stones (vesical calculi).” Updated 2023. https://www.mayoclinic.org
- World Health Organization. “Epidemiology of urinary calculi.” WHO Bulletin, 2022.
- National Institutes of Health – National Institute of Diabetes and Digestive and Kidney Diseases. “Kidney Stones.” 2024. https://www.niddk.nih.gov
- Cleveland Clinic. “Bladder Stones Treatment.” 2023. https://my.clevelandclinic.org
- American Urological Association. “Guideline on the Management of Urolithiasis.” 2023. https://www.auanet.org
- Centers for Disease Control and Prevention. “Urinary Tract Infection (UTI) Facts.” 2024. https://www.cdc.gov